HERVolution Therapeutics: Dark Genome Biotech Company Raises $11.7 Million (Series A ...

HERVolution Therapeutics raised $11.7M in Series A funding led by Serum Institute of India and European Innovation Council Fund to advance HERV-targeting immunotherapies for aging-related diseases. The funding will support cGMP manufacturing, Phase 1 studies, and infrastructure expansion. HERVolution's proprietary approach breaks immune tolerance to HERVs, enabling new therapeutic applications.